Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Pedersen, Katrina S ^a   Bamlet, William R ^a   Oberg, Ann L ^a   de Andrade, Mariza ^a   Matsumoto, Martha E ^a   Tang, Hui ^a   Thibodeau, Stephen N ^a   Petersen, Gloria M ^a   Wang, Liang ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; BISULFITE; SULFITE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CPG ISLAND; DISEASE MARKER; DNA METHYLATION; EARLY DIAGNOSIS; EPIGENETICS; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PREDICTION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR;

AGED; AGED, 80 AND OVER; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; QUANTITATIVE TRAIT LOCI; SULFITES;

EID: 79953046715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018223     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300.
2. NCI (2010) SEER Stat Fact Sheets: Pancreas. National Cancer Institute.
3. USPSTF (2004) The U.S. Preventive Services Task Force Guidelines: Screening for Pancreatic Cancer.
4. Feinberg AP, (2008) Epigenetics at the epicenter of modern medicine. JAMA 299: 1345-1350.
5. Duffy MJ, Napieralski R, Martens JW, Span PN, Spyratos F, et al. (2009) Methylated genes as new cancer biomarkers. Eur J Cancer 45: 335-346.
6. Lopez J, Percharde M, Coley HM, Webb A, Crook T, (2009) The context and potential of epigenetics in oncology. Br J Cancer 100: 571-577.
7. Fukushima N, Walter KM, Uek T, Sato N, Matsubayashi H, et al. (2003) Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2: 78-83.
8. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, et al. (2002) Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 1: 293-296.
9. Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, et al. (2003) Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 9: 1446-1452.
10. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, et al. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63: 3735-3742.
11. Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio-Donahue CA, et al. (2005) Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 24: 850-858.
12. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, et al. (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60: 1835-1839.
13. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, et al. (2006) DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 66: 1208-1217.
14. Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, et al. (2009) Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol 3: 425-438.
15. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, et al. (2007) Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16: 108-114.
16. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, et al. (2008) Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 9: 359-366.
17. Wang L, Aakre JA, Jiang R, Marks RS, Wu Y, et al. (2010) Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol 5: 778-785.
18. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, et al. (2008) Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 3: e2656.
19. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
20. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
21. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42: 224-228.
22. Tibshirani R, (1996) Regression shrinkage and selection via the lasso. J Royal Statist Soc B 58: 267-288.
23. Goeman JJ, (2010) L1 penalized estimation in the Cox proportional hazards model. Biom J 52: 70-84.
24. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R, (2004) Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101: 2727-2736.
25. Poch B, Lotspeich E, Ramadani M, Gansauge S, Beger HG, et al. (2007) Systemic immune dysfunction in pancreatic cancer patients. Langenbecks Arch Surg 392: 353-358.
26. Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, et al. (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5: e123.
27. Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, et al. (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 98: 1540-1547.
28. Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, et al. (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 68: 6100-6108.
29. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, et al. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20: 170-179.
30. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, et al. (2009) The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 4: e6767.
31. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, et al. (2008) Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 40: 904-908.
32. Zhang Y, Rohde C, Tierling S, Jurkowski TP, Bock C, et al. (2009) DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet 5: e1000438.
33. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, et al. (2010) Abundant quantitative trait Loci exist for DNA methylation and gene expression in human brain. PLoS Genet 6: e1000952.